Actinogen Medical funded beyond November results

By Proactive Investors / August 03, 2026 / www.youtube.com / Article Link


Actinogen Medical has kept its pivotal XanaMIA Alzheimer's disease trial on schedule for topline results in November 2026.

Recent News

Big Gold's strong Q2/26 results continue
August 03, 2026 / www.canadianminingreport.com

Gold stocks see moderate declines

August 03, 2026 / www.canadianminingreport.com

Market still expecting strong growth for major gold producers
July 27, 2026 / www.canadianminingreport.com

Newmont starts Q2/26 strong, growth expected for gold majors
July 27, 2026 / www.canadianminingreport.com

Gold not the consensus play anymore
July 20, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok